T. Meyer

Sorafenib for the Treatment of Advanced Hepatocellular Cancer - a UK Audit.

C. Braconi, P. Ross, P. Collins, 2017, Clinical oncology (Royal College of Radiologists (Great Britain)).

Phase I Study of Sequence-Selective Minor Groove DNA Binding Agent SJG-136 in Patients with Advanced Solid Tumors

R. Begent, P. Loadman, D. Hochhauser, 2009, Clinical Cancer Research.

A comparison of Hickman line- and Port-a-Cath-associated complications in patients with solid tumours undergoing chemotherapy.

D. Hochhauser, J. Tibballs, H. Mastoroudes, 2007, Clinical oncology (Royal College of Radiologists (Great Britain)).

Assessment of pegylated arginine deiminase and modified FOLFOX6 in patients with advanced hepatocellular carcinoma: Results of an international, single‐arm, phase 2 study

G. Abou-Alfa, J. Harding, C. Yen, 2021, Cancer.

SO-9 Outcomes for patients with advanced hepatocellular carcinoma and Child-Pugh B liver function in the phase 3 CELESTIAL study of cabozantinib vs placebo

G. Abou-Alfa, A. El-Khoueiry, L. Rimassa, 2020 .

Corrigendum to "Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up": [Annals of Oncology 29 suppl. 4 (2018) v238-iv255].

J. Llovet, B. Sangro, C. Verslype, 2022, Annals of oncology : official journal of the European Society for Medical Oncology.

Phase I Study of Sequence-Selective Minor Groove DNA Binding Agent SJG-136 in Patients with Advanced Solid Tumors

R. Begent, P. Loadman, D. Hochhauser, 2009, Clinical Cancer Research.

Phase III randomized study of second line ADI-PEG 20 plus best supportive care versus placebo plus best supportive care in patients with advanced hepatocellular carcinoma

F. Izzo, M. Colombo, Sheng-Nan Lu, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

Nivolumab in sorafenib-naive and sorafenib-experienced patients with advanced hepatocellular carcinoma: 5-year follow-up from CheckMate 040.

A. El-Khoueiry, S. Choo, J. Neely, 2023, Annals of oncology : official journal of the European Society for Medical Oncology.